Nonprescription Drugs Advisory Committee October 20, 2005

Jul 31, 2014

80 likes | 173 Views

Nonprescription Drugs Advisory Committee October 20, 2005. Open Public Hearing Speakers. Donald A. Goldman, M.D. Sally Bloomfield, BPharm, PhD Chairman and Scientific Advisory Board Member, IFH Hon. Professor, London School of Hygiene and Tropical Medicine. Lawton Seal, PhD

Share Presentation

Embed Code

Link

drexel university
open public hearing
charles n
october
eugene c
scientific advisory board member

ursala

Download Presentation

Nonprescription Drugs Advisory Committee October 20, 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Nonprescription Drugs Advisory Committee October 20, 2005 Open Public Hearing Speakers
Donald A. Goldman, M.D.
Sally Bloomfield, BPharm, PhD Chairman and Scientific Advisory Board Member, IFH Hon. Professor, London School of Hygiene and Tropical Medicine
Lawton Seal, PhD Sr. Program Manager Healthpoint R&D
Charles N. Haas Drexel University
Tammy Lundstrom
Howard Bochnek
Eugene C. Cole, DrPH Brigham Young University Provo, Utah

FDA Medical Imaging Drugs Advisory Committee

FDA Medical Imaging Drugs Advisory Committee. July 10, 2000 BLA 99-1407 LeuTech ® Palatin Technologies, Inc. CP000.02. CP001.01. Palatin Presenters. Charles Putnam Chief Operating Officer Palatin Technologies, Inc.

1.26k views • 92 slides

FDA’s Oncologic Drugs Advisory Committee Meeting

FDA’s Oncologic Drugs Advisory Committee Meeting. DASATINIB (BMS-354825). 2 June 2006. Donna Morgan Murray, PhD Bristol-Myers Squibb Global Regulatory Sciences. Introduction. BMS Presentation. Introduction . ……………….. Donna Morgan Murray, PhD BMS, Global Regulatory Sciences

892 views • 65 slides

Nonprescription Drugs And Reproductive Health Drugs Joint Advisory Committee Meeting December 16, 2003

Nonprescription Drugs And Reproductive Health Drugs Joint Advisory Committee Meeting December 16, 2003. Plan B ® (LEVONORGESTREL) For Emergency Contraception R X -to-OTC SWITCH . Plan B ® : R X -to-OTC Switch . Carole S. Ben-Maimon, M.D. President and COO, Barr Research

1.28k views • 99 slides

Pulmonary - Allergy Drugs Advisory Committee Meeting

Pulmonary - Allergy Drugs Advisory Committee Meeting. January 17, 2002 FLOVENT® DISKUS® NDA 20-833 ADVAIR DISKUS® NDA 21-077. FLOVENT® DISKUS® and ADVAIR DISKUS®. David Wheadon, MD Senior Vice President, Regulatory Affairs GlaxoSmithKline. sNDAs for FLOVENT DISKUS and ADVAIR DISKUS.

1.42k views • 120 slides

ENG Advisory Committee May 11, 2005

ENG Advisory Committee May 11, 2005. BES OVERVIEW Bruce Hamilton Acting Division Director. BES Structure & Funding Profile. Three (3) Clusters: Biochemical Engineering/Biotechnology (BEB) Biomedical Engineering/Research to Aid Persons with Disabilities (BME/RAPD)

343 views • 20 slides

LINC Advisory Committee October 29, 2008

Topics of the Meeting. Elementary Principal Survey (Preliminary Results)Policy ScanDiscussion on the Conceptual MapNext Steps. . LINC Principal Survey Demographics. Sent to Illinois elementary school principals, 166 respondedLocation:CPS, n=8 (5%)Collar County, 30% (n=50)Large Town (pop. 25,0

316 views • 20 slides

FDA Anti-Infective Drugs Advisory Committee, October 2003

Diabetic foot infection: what remains to be discovered?. Dr. Tony Berendt, BM, BCh, FRCP Bone Infection Unit, Oxford. FDA Anti-Infective Drugs Advisory Committee, October 2003. Take home messages. Despite considerable advances, there is much we do not know about diabetic foot infection

873 views • 40 slides

Oncologic Drugs Advisory Committee February 27, 2002

Issues in the Clinical Development of Investigational Agents Being Evaluated for the Post-surgical Adjuvant Treatment of High-Risk (Stage IIb and III) Melanoma. Oncologic Drugs Advisory Committee February 27, 2002. Adjuvant Treatment for Malignant Melanoma Outline of Presentation.

995 views • 78 slides

Advisory Committee Meeting (2005-06)

Advisory Committee Meeting (2005-06). Agenda Items. Progress report of year 2004-2005. Audit report of year 2004-2005. Operational Plan year 2005-2006. Progress report of year 2005-2006 up to 30-9-05. Any other Item with the permission of Chair. June 10, 2014.

385 views • 25 slides

Antiviral Drugs Advisory Committee Meeting

Antiviral Drugs Advisory Committee Meeting. Raltegravir NDA 22-145 September 5, 2007. NDA 22-145 : Isentress™ (raltegravir potassium) Applicant : Merck & Co., Inc. Formulation : 400 mg tablets Indication : HIV-1 treatment-experienced adult patients.

345 views • 10 slides

Budget Advisory Committee October 11, 2013

Budget Advisory Committee October 11, 2013. Academic Department OTPS Resource Distribution Model Recap. 2013-14 OTPS /Recharge budgets determined by model Total budget increased by $ 3.8k v. FY12 /13 Additional funds added for net increase in faculty lines Enrollment relatively flat.

238 views • 11 slides

FDA Endocrine and Metabolic Drugs Advisory Committee October 7, 2003

FDA Endocrine and Metabolic Drugs Advisory Committee October 7, 2003. Joseph S. Camardo, M.D. Senior Vice President Clinical Research. Agenda. Introduction and Overview: Use of estrogen/progestin for osteoporosis The clinical data for estrogen/progestin The WHI data and clinical practice

496 views • 36 slides

Psychopharmacology Drug Advisory Committee (PDAC) Meeting October 25, 2005

Psychopharmacology Drug Advisory Committee (PDAC) Meeting October 25, 2005. Joseph Camardo, MD Senior VP, Global Medical Affairs. Questions We Should Ask Ourselves. What are the strengths & weaknesses of the proposed changes?

237 views • 6 slides

Web Advisory Committee May 20, 2009

Web accessiblity. Web Advisory Committee May 20, 2009. Pending Ontario legislation. Accessibility for Ontarians with Disabilities Act Accessible Information & Communications Standard This standard will eventually become law. Questions.

169 views • 8 slides

FDA’s Antiviral Drugs Advisory Committee Meeting

FDA’s Antiviral Drugs Advisory Committee Meeting. BARACLUDE TM (entecavir / BMS 200475). 11 March 2005. Introduction. Elliott Sigal, MD, PhD. Global Impact of Hepatitis B. 15–40% develop cirrhosis, liver failure or hepatocellular carcinoma. 2 billion with past / present HBV infection.

1.04k views • 88 slides

Genealogy October 20, 2005

Genealogy October 20, 2005. More than Who and When Include Where and Why Tell a story. Rules of the Game. Play detective Search for clues Evaluate the meaning of the clues Are they telling you the truth or leading you down a false trail and wrong conclusions Document what you learn.

561 views • 45 slides

Advisory Committee for Pharmaceutical Science (ACPS) October 26, 2005

Implementation of Quality-by-Design Principles in CMC Review: Office Of New Drug Chemistry Approach. Chi-wan Chen, Ph.D. Deputy Director Office of New Drug Chemistry. Advisory Committee for Pharmaceutical Science (ACPS) October 26, 2005. Outline.

488 views • 28 slides

New Advisory Committee Member Training - April 20, 2005

FDA Website www.fda.gov It’s Big… More than 600,000 pages Growing at >20 percent a year. New Advisory Committee Member Training - April 20, 2005. FDA Website www.fda.gov It’s Busy… Every Day: 4.7 million hits 1.7 million page views

170 views • 6 slides

Pulmonary-Allergy Drugs Advisory Committee July 13, 2005

Pulmonary-Allergy Drugs Advisory Committee July 13, 2005. Safety of long-acting beta-agonist bronchodilators Badrul A. Chowdhury, MD, PhD Director Division of Pulmonary and Allergy Drug Products. Question 1.

176 views • 5 slides

Advisory Group Meeting 12 October 2005

Advisory Group Meeting 12 October 2005. ‘Create once, use many times’. The Clever Use of Metadata in eGovernment and eBusiness Recordkeeping Processes in Networked Environments. Outline. Metadata re-use and Interoperability Issues Metadata Broker Development Service Oriented Architectures

320 views • 19 slides

Psychopharmacologic Drugs Advisory Committee June 16, 2003

Psychopharmacologic Drugs Advisory Committee June 16, 2003. Tarek A. Hammad, MD, PhD, MSc, MS Medical Reviewer Division of Neuropharmacological Drug Products Center for Drug Evaluation and Research, FDA. 1. Outline. Generic Drugs Registry Data Are We Seeing the Full Picture?

304 views • 17 slides

TSE Advisory Committee October 25, 2001

TSE Advisory Committee October 25, 2001. Topic 3. Center for Food Safety and Applied Nutrition Food and Drug Administration Washington, DC 20204. Topic 3. Bovine Brain, Spinal Cord, and Other Neurological Tissue in Foods, Drugs, and Cosmetics for Human Use. Purpose.

278 views • 14 slides

More Related